SCHEMBL208358

SCHEMBL208358

CC(=O)OCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28729219 0.97
Ammonia Solution, Strong SCHEMBL27984531 0.97
SCHEMBL27992551 0.97
Carbamic Acid SCHEMBL29768869 0.90 ALDH1A1 (0.40)
P-Xylene SCHEMBL27574243 0.84 LMNA (0.47)
Trifluoroacetic Acid SCHEMBL29768876 0.84 ALDH1A1 (0.36)
SCHEMBL30885573 0.82 ALDH1A1 (0.43)
SCHEMBL16072478 0.81 ALDH1A1 (0.37)
SCHEMBL6383596 0.79 ALDH1A1 (0.41)
SCHEMBL74779 0.79 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 762 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3897962-B1 METHODS AND PRODUCTS FOR CONVERTING CARBON DIOXIDE TO ONE OR MORE SMALL ORGANIC COMPOUNDS CARBONX DEV PTY LTD (AU) 2025-11-12 EP claimed
US-20220089575-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF ORGANOVO, INC. 2022-03-24 US claimed
EP-2975405-B1 PROCESSES FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS ENZO LIFE SCIENCES INC (US) 2018-03-07 EP claimed
EP-2975405-A1 PROCESSES FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS Enzo Life Sciences, Inc. (US) 2016-01-20 EP claimed
US-9097673-B2 Processes and kits for determining multi-drug resistance of cells ENZO LIFE SCIENCES, INC. (US) 2015-08-04 US claimed
US-20130323773-A1 PROCESSES AND KITS FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS ENZO LIFE SCIENCES, INC. 2013-12-05 US claimed
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP claimed
US-8530650-B2 2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer MERCK PATENT GMBH (DE) 2013-09-10 US claimed
US-8445271-B2 Processes and kits for determining multi-drug resistance of cells ENZO LIFE SCIENCES, INC. (US) 2013-05-21 US claimed
EP-2567233-A1 PROCESSES AND KITS FOR DETERMINING MULTI-DRUG RESISTANCE OF CELLS Enzo Life Sciences, Inc. (US) 2013-03-13 EP claimed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO claimed
CN-1353709-A Bicyclic oxazolidinones as antibacterial agents PHARMACIA & UP JOHN CO (US) 2002-06-12 CN claimed
US-6348504-B1 COMPOUNDS WITH AMIDINE OR GUANIDINE GROUPS AND CARBOXY OR ESTER GROUPS THROMBOLYTICS AND/OR FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS. DUPONT PHARMACEUTICALS COMPANY 2002-02-19 US claimed
CN-1074306-C Catalyst for synthesizing alcohol, acetic acid and acetaldehyde etc. dicarbonic oxy-combound by carbon monoxide hydronation DALIAN CHEMICAL PHYSICS INST (CN) 2001-11-07 CN claimed
EP-0206741-B1 LEUKOTRIENE ANTAGONISTS MERCK FROSST CANADA INC. (CA) 1991-04-10 EP claimed
EP-0268931-B1 PROCESS FOR PREPARING 2-SUBSTITUTED 4-ACYLOXY-2-BUTENALS BASF Aktiengesellschaft (DE) 1990-08-01 EP claimed
US-4873362-A REACTING AN ACYLOXYACETALDEHYDE WITH AN ALDEHYDE USING AN AMINE AND ACID CATALYST SYSTEM BASF AKTIENGESELLSCHAFT (DE) 1989-10-10 US claimed
EP-0206741-A2 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1986-12-30 EP claimed
EP-0174770-A1 Leukotriene antagonists, their preparation, use pharmaceutical compositions containing them and methods of making them MERCK FROSST CANADA INC. (CA) 1986-03-19 EP claimed
EP-0064129-B1 A COMPOSITION FOR COATING A MAGNETIC RECORDING MEMBER International Business Machines Corporation (US) 1985-12-04 EP claimed